Abstract
According to data from the WHO, heart disease continues to be the top cause of mortality worldwide. The 2018 Riskesdas shows that the prevalence of heart disease, including CAD, based on doctors' diagnoses in Indonesia is 1,5%. Management measures in CAD patients are CABG or PCI. The research design used in this study was a literature review using a systematic review method. A systematic literature review comparing CABG and PCI costs is needed to determine optimal therapeutic options in CAD patients. For articles published during the last ten years, a literature search was done using four databases: PubMed, SagePub, Google Scholar, and Science Direct. Based on the Preferred Reporting Items for Systematic Review and Meta-Analyses Protocol (PRISMA-P) 2020 protocol, a literature review was conducted. Eight texts in all met the inclusion and exclusion criteria for the study. Five literatures stating that CABG is better, two other literatures stating that there is no significant post-rehabilitation difference between CABG and PCI, and one literature stating that PCI has better survival after 5 years in CAD patients with impaired renal function. CABG is considered more effective and is recommended as the primary treatment option in CAD patients with a kidney disorder. Nevertheless, PCI can be utilized as an alternate therapy in CAD patients when kidney function and concomitant illnesses are considered.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
